Showing results (1121-1130 of 2,753) with videos related to
Sort By:
Pageof 276
Oncology (Williston Park, N.Y.)|July 17, 2017
Myeloproliferative Neoplasms: Translating New Discoveries Into Better Outcomes, Better Quality of LifeLeslie Padrnos, Ruben A MesaOncology (Williston Park, N.Y.)|July 17, 2017
Precision Medicine in Metastatic Colorectal Cancer: Relevant Carcinogenic Pathways and Targets-PART 1: Biologic Therapies Targeting the Epidermal Growth Factor Receptor and Vascular Endothelial Growth FactorBenjamin A Weinberg, Marion L Hartley, Mohamed E SalemOncology (Williston Park, N.Y.)|February 16, 2018
Fear of Cancer Recurrence: A Practical Guide for CliniciansPhyllis Butow, Louise Sharpe, Belinda Thewes, et al.Oncology (Williston Park, N.Y.)|January 4, 2018
Treatment of HIV-Associated Lymphomas: The Latest Approaches for Optimizing OutcomesNatasha B Hunter, Samantha Vogt, Richard F AmbinderOncology (Williston Park, N.Y.)|January 4, 2018
Emergence of a Novel Staging System for Oropharyngeal Squamous Cell Carcinoma Based on HPV StatusAru Panwar, Erik Interval, William M LydiattOncology (Williston Park, N.Y.)|March 17, 2018
Immunotherapy Plus Stereotactic Radiosurgery: Building on the Promise of Precision Medicine for CNS Malignancies-PART 2: Existing Experience and Considerations for Future TrialsIsabella Zhang, Silvia C Formenti, Jonathan P S KniselyOncology (Williston Park, N.Y.)|January 12, 2019
Immunotherapeutic Approaches to the Management of Head and Neck CancerXinyu Nan, Kathryn A Gold, Ezra CohenOncology (Williston Park, N.Y.)|November 27, 2018
Considerations in the Care of Non-Small-Cell Lung Cancer: The Value ImperativeRonan Kelly, Stefanie HouseknechtOncology (Williston Park, N.Y.)|October 12, 2007
Evolving role of novel targeted agents in renal cell carcinomaThomas E Hutson, Robert A FiglinOncology (Williston Park, N.Y.)|April 24, 2009
Anaphylaxis: implications of monoclonal antibody use in oncologyGerald J Gleich, Kristin M LeifermanPageof 276